Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Chatbot vs. paper: which teaches caregivers better?

NCT ID NCT07463443

Knowledge-focused Sponsor: Taipei Veterans General Hospital, Taiwan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 15, 2026 · Updated 4 times

Summary

This study tests whether a chatbot called 'Pneumonia Care Helper' can improve the knowledge, attitudes, and caregiving skills of people caring for elderly pneumonia patients. 150 caregivers will either use the chatbot with educational videos for 5 days or receive standard paper instructions. The goal is to see if digital tools can provide better, more interactive support than traditional methods.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Chatbot with educational videos
What this could lead to
If it works, this could point toward a simple, scalable way to support family caregivers at home, improving patient recovery and reducing hospital readmissions.
What could go wrong
This is a small, early-stage study with only 150 participants over 5 days. The chatbot may not improve knowledge or care practices more than standard paper instructions, and results may not apply to other settings or languages.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with a primary diagnosis of pneumonia during the current hospitalization. * Patients aged 65 years or older. * Primary caregivers aged 18 years or older. * Primary caregivers who can read and understand Mandarin Chinese. * Primary caregivers who own a mobile device (e.g., smartphone or tablet) and can use the chatbot application. Exclusion Criteria: * Primary caregivers who do not live with the patient. * Primary caregivers who have received formal training as professional nursing assistants or caregivers. * Primary caregivers who are currently or were formerly healthcare professionals (e.g., physicians, nurses, therapists). * Primary caregivers who do not possess a mobile device or are unable to use chatbot applications.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chatbot are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chatbot Family caregivers Geriatric patient Knowledge, attitudes, practice Pneumonia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Taipei Veterans General Hospital

    RECRUITING

    Taipei, Taiwan, 112201, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.